Literature DB >> 26541925

The role of the clinical pharmacist in the care of patients with cardiovascular disease.

Steven P Dunn1, Kim K Birtcher2, Craig J Beavers3, William L Baker4, Sara D Brouse3, Robert L Page5, Vera Bittner6, Mary Norine Walsh7.   

Abstract

Team-based cardiovascular care, including the use of clinical pharmacists, can efficiently deliver high-quality care. This Joint Council Perspectives paper from the Cardiovascular Team and Prevention Councils of the American College of Cardiology provides background information on the clinical pharmacist's role, training, certification, and potential utilization in a variety of practice models. Selected systematic reviews and meta-analyses, highlighting the benefit of clinical pharmacy services, are summarized. Clinical pharmacists have a substantial effect in a wide variety of roles in inpatient and ambulatory settings, largely through optimization of drug use, avoidance of adverse drug events, and transitional care activities focusing on medication reconciliation and patient education. Expansion of clinical pharmacy services is often impeded by policy, legislation, and compensation barriers. Multidisciplinary organizations, including the American College of Cardiology, should support efforts to overcome these barriers, allowing pharmacists to deliver high-quality patient care to the full extent of their education and training.
Copyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  collaborative practice; medication adherence; medication therapy management; team-based care

Mesh:

Year:  2015        PMID: 26541925     DOI: 10.1016/j.jacc.2015.09.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  32 in total

1.  Impact of a Clinical Pharmacy Service on the Management of Patients in a Sickle Cell Disease Outpatient Center.

Authors:  Jin Han; Shubha Bhat; Michel Gowhari; Victor R Gordeuk; Santosh L Saraf
Journal:  Pharmacotherapy       Date:  2016-10-03       Impact factor: 4.705

Review 2.  Cost-Effectiveness and Challenges of Implementing Intensive Blood Pressure Goals and Team-Based Care.

Authors:  Catherine G Derington; Jordan B King; Kelsey B Bryant; Blake T McGee; Andrew E Moran; William S Weintraub; Brandon K Bellows; Adam P Bress
Journal:  Curr Hypertens Rep       Date:  2019-11-07       Impact factor: 5.369

3.  Feasibility of a Telemedicine-Administered, Pharmacist-Staffed, Protocol-Driven, Multicenter Program for Kidney Stone Prevention in a Large Integrated Health Care System: Results of a Pilot Program.

Authors:  Mark E Gasparini; Toby W Chang; Mark St Lezin; John E Skerry; Andy Chan; Krishna A Ramaswamy
Journal:  Perm J       Date:  2019-11-01

4.  Modeling the Health and Budgetary Impacts of a Team-based Hypertension Care Intervention That Includes Pharmacists.

Authors:  Katherine J Overwyk; Steven P Dehmer; Kakoli Roy; Michael V Maciosek; Yuling Hong; Madeleine M Baker-Goering; Fleetwood Loustalot; Christa-Marie Singleton; Matthew D Ritchey
Journal:  Med Care       Date:  2019-11       Impact factor: 2.983

Review 5.  Deprescribing in Older Adults With Cardiovascular Disease.

Authors:  Ashok Krishnaswami; Michael A Steinman; Parag Goyal; Andrew R Zullo; Timothy S Anderson; Kim K Birtcher; Sarah J Goodlin; Mathew S Maurer; Karen P Alexander; Michael W Rich; Jennifer Tjia
Journal:  J Am Coll Cardiol       Date:  2019-05-28       Impact factor: 24.094

6.  Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study.

Authors:  Iyn-Hyang Lee; Sandy Jeong Rhie; Nam Kyung Je; Ki Yon Rhew; Eunhee Ji; Jung Mi Oh; Euni Lee; Jeong-Hyun Yoon
Journal:  Int J Clin Pharm       Date:  2016-08-31

7.  PREVENTIVE CARDIOLOGY AS NEW SUBSPECIALTY OF CARDIOVASCULAR MEDICINE.

Authors:  Sergio Fazio; Michael D Shapiro
Journal:  Trans Am Clin Climatol Assoc       Date:  2020

8.  Work Profile Factors Identified From the Career Pathway Evaluation Program, 2018 Pharmacist Profile Survey.

Authors:  Jon C Schommer; Elliott M Sogol; Lawrence M Brown
Journal:  Am J Pharm Educ       Date:  2019-12       Impact factor: 2.047

Review 9.  Cardiovascular Risk Reduction by Pharmacists at the Workplace.

Authors:  Tracy E Macaulay; Sarah Schaidle; Nathan Wayne
Journal:  Curr Cardiol Rep       Date:  2020-02-07       Impact factor: 2.931

10.  The involvement of pharmacies in the screening of undiagnosed atrial fibrillation.

Authors:  Pietro Amedeo Modesti; Gianni Donigaglia; Plinio Fabiani; Nicola Mumoli; Andrea Colella; Maria Boddi
Journal:  Intern Emerg Med       Date:  2017-09-19       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.